LifeVantage (NASDAQ:LFVN) Share Price Passes Below Two Hundred Day Moving Average of $6.42

LifeVantage Co. (NASDAQ:LFVNGet Free Report)’s stock price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $6.42 and traded as low as $6.03. LifeVantage shares last traded at $6.05, with a volume of 42,786 shares trading hands.

LifeVantage Trading Down 3.7 %

The stock has a market cap of $79.40 million, a PE ratio of 26.83 and a beta of 0.78. The business has a 50-day moving average price of $6.59 and a 200-day moving average price of $6.42.

LifeVantage (NASDAQ:LFVNGet Free Report) last announced its earnings results on Tuesday, January 30th. The company reported $0.10 earnings per share (EPS) for the quarter. LifeVantage had a return on equity of 19.96% and a net margin of 1.40%. The firm had revenue of $51.62 million for the quarter.

LifeVantage Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were issued a $0.035 dividend. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $0.14 dividend on an annualized basis and a yield of 2.27%. LifeVantage’s payout ratio is currently 60.87%.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in LifeVantage stock. Ritholtz Wealth Management lifted its stake in shares of LifeVantage Co. (NASDAQ:LFVNFree Report) by 23.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 25,027 shares of the company’s stock after acquiring an additional 4,756 shares during the period. Ritholtz Wealth Management owned 0.20% of LifeVantage worth $150,000 as of its most recent filing with the Securities & Exchange Commission. 35.32% of the stock is owned by institutional investors and hedge funds.

About LifeVantage

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Featured Stories

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.